Literature DB >> 11960203

Glucorticoids and bone: some general remarks and some special observations in pediatric patients.

Maria Luisa Bianchi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960203     DOI: 10.1007/s00223-001-0043-0

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  13 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls.

Authors:  M S Fewtrell
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

Review 3.  Zoledronic acid in pediatric metabolic bone disorders.

Authors:  Sasigarn A Bowden; John D Mahan
Journal:  Transl Pediatr       Date:  2017-10

4.  Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.

Authors:  Shojiro Akahoshi; Akinori Sakai; Shinobu Arita; Satoshi Ikeda; Yoshiomi Morishita; Hideki Tsutsumi; Masako Ito; Ayako Shiraishi; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

5.  Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS.

Authors:  Gabriella Aceto; Olinda D'Addato; Giovanni Messina; Vincenza Carbone; Luciano Cavallo; Giacomina Brunetti; Maria Felicia Faienza
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

Review 6.  Can bisphosphonates play a role in the treatment of children with chronic kidney disease?

Authors:  Dieter Haffner; Dagmar-Christiane Fischer
Journal:  Pediatr Nephrol       Date:  2011-01-27       Impact factor: 3.714

Review 7.  Glucocorticoid-induced osteoporosis: who to treat with what agent?

Authors:  René Rizzoli; Emmanuel Biver
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

8.  Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro".

Authors:  Valéria F Caparbo; Flávia Prada; Clóvis A A Silva; Paula L Regio; Rosa M R Pereira
Journal:  Clin Rheumatol       Date:  2008-08-07       Impact factor: 2.980

Review 9.  Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods.

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-02-12

10.  Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment.

Authors:  Eftichia Korakaki; Dimitrios Gourgiotis; Agisilaos Aligizakis; Antonia Manoura; Eleftheria Hatzidaki; Emmanuel Giahnakis; Antonios Marmarinos; Maria Kalmanti; Christina Giannakopoulou
Journal:  J Bone Miner Metab       Date:  2007-04-20       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.